In today's global research environment timely accrual of qualified study subjects has become one of the biggest challenges facing companies that are developing new therapies and treatments. Latin American and in particular Brazil is one of the few areas of the world with large accessible oncology patient populations. Oncopartners in partnership with IBPC provides centralized access to a select group of large oncology referral centers with experienced cancer trial researchers and the patient population to meet aggressive accrual targets. By networking physicians in Latin America with U.S. counterparts, Oncopartners provides an unprecedented advantage to both study sponsors and patients.
Founded in 2007, Oncopartners, in conjunction with the largest non-profit network of public oncology hospitals in Brazil (IBPC), is today providing biotechnology and pharmaceutical sponsors with well-managed access to a population of 190 million citizens. Recent major improvements in the regulatory environment have increased the attractiveness of including Brazilian sites in global oncology programs and we are ideally positioned to enable our sponsors in this region. Focusing solely on oncology, Oncopartners has established offices in São Paulo, Brazil and is currently supporting pharmaceutical, biotechnology and global CROs with their respective oncology programs.
With an experienced operational staff including four physicians, Oncopartners and IBPC work as part of a sponsor's global team and in concert with CROs to provide outstanding protocol consultation, regulatory submissions, full project management, study monitoring and medical support expertise. Our ability to effectively combine the efforts of on-site Principal Investigators, sub-Investigators and support personnel with that of our central staff in São Paulo, enables us to achieve outstanding enrollment rates and data quality. We invite you to find out how Oncopartners can help accelerate your oncology clinical trials.